Publications en collaboration avec des chercheurs de Hospital de Poniente (25)

2024

  1. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

    Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

  2. DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain

    Viruses, Vol. 16, Núm. 2

2023

  1. Autosomal dominant polycystic kidney disease in young adults

    Clinical Kidney Journal, Vol. 16, Núm. 6, pp. 985-995

2022

  1. Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study

    Medicina Intensiva, Vol. 46, Núm. 4, pp. 179-191

  2. Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease

    Frontiers in Medicine, Vol. 9

2021

  1. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

    Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810

  2. Miliaria crystallina induced by idarubicin and all-trans-retinoic acid: Two case reports

    Australasian Journal of Dermatology, Vol. 62, Núm. 3, pp. e408-e410

  3. Progression to hepatitis C virus micro-elimination in people living with HIV in Spain

    Clinical Microbiology and Infection

2020

  1. A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 3, pp. 222-228

2019

  1. Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR

    Scientific Reports, Vol. 9, Núm. 1

  2. Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients

    HIV Medicine, Vol. 20, Núm. 6, pp. 359-367

  3. Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort

    PLoS ONE, Vol. 14, Núm. 8

  4. Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology setting

    Actas Urologicas Espanolas, Vol. 43, Núm. 7, pp. 364-370

2018

  1. Estudio CRONO: Prevalencia del dolor irruptivo en pacientes con dolor crónico no oncológico en Andalucía, España

    Revista de la Sociedad Espanola del Dolor, Vol. 25, Núm. 4, pp. 214-221

2017

  1. A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

    Respiratory Research, Vol. 18, Núm. 1

  2. Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494

  3. Reconstruction Techniques of Choice for the Facial Cosmetic Units

    Actas Dermo-Sifiliograficas, Vol. 108, Núm. 8, pp. 729-737

2016

  1. Sarcoidosis: an update on current pharmacotherapy options and future directions

    Expert Opinion on Pharmacotherapy, Vol. 17, Núm. 18, pp. 2431-2448

2015

  1. Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 34, Núm. 11, pp. 2247-2255

2012

  1. Antibiotic prescription patterns in the empiric therapy of severe sepsis: Combination of antimicrobials with different mechanisms of action reduces mortality

    Critical Care, Vol. 16, Núm. 6